J2351 Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
Short descriptor: Inj ocrelizumab 1mg hya-ocsq
Look up J2351 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J2351 is the HCPCS Level II code for Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2025-04-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- ocrelizumab
- Dose / Unit
- 1 mg and hyaluronidase-ocsq
- Route
- Injection
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J2351 with the canonical source and edition:
J2351 — Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J2351
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J2351